| First group Tyg ≤ 8.493 | Middle group Tyg 8.494–9.022 | Third group Tyg ≥ 9.023 | P.value |
---|---|---|---|---|
 | N = 288 | N = 288 | N = 288 | |
Mean age (SD), y | 67.4 (14.2) | 67.4 (14.3) | 68.2 (13.2) | 0.734 |
Male sex (%) | 159 (55.2) | 161 (55.9) | 158 (54.9) | 0.968 |
Paroxysmal AF (%) | 158 (54.9) | 166 (57.6) | 173 (60.1) | 0.449 |
Catheter ablation (%) | 120 (41.7) | 119 (41.3) | 69 (24.0) | < 0.001 |
Weight (SD), kg | 61.1 (12.5) | 63.7 (13.5) | 64.7 (13.0) | 0.006 |
Unknown (%) | 20 (6.9) | 27 (9.4) | 32 (11.1) | Â |
Height (SD), m | 1.62 (0.09) | 1.63 (0.09) | 1.62 (0.09) | 0.584 |
Unknown (%) | 10 (3.5%) | 19 (6.6) | 17 (5.9) | Â |
Systolic pressure (SD), mmHg | 130 (19.5) | 129 (19.9) | 129 (23.0) | 0.733 |
Diastolic pressure (SD), mmHg | 80.7 (13.7) | 80.5 (13.5) | 80.0 (14.7) | 0.798 |
CHA2DS2-VASc (SD) | 2.84(1.86) | 2.82(1.92) | 3.18(1.94) | 0.038 |
Comorbidities (%) | Â | Â | Â | Â |
Hypertension | 150 (52.1) | 133 (46.2) | 145 (50.3) | 0.346 |
Heart failure | 86 (29.9) | 95 (33.0) | 118 (41.0) | 0.015 |
Stroke/TIA | 47 (16.3) | 49 (17.0) | 54 (18.8) | 0.730 |
Systemic embolism | 1 (0.4) | 6 (2.1) | 12 (4.2) | 0.007 |
Coronary artery disease | 60 (20.8) | 59 (20.5) | 85 (29.5) | 0.015 |
Peripheral artery disease | 25 (8.7) | 13 (4.5) | 17 (5.9) | 0.114 |
COPD | 33 (11.5) | 23 (8.0) | 30 (10.4) | 0.361 |
Sleep disorders | 11 (3.8) | 14 (4.9) | 9 (3.1) | 0.559 |
Hyperthyroidism | 4 (1.4) | 10 (3.5) | 1 (0.4) | 0.014 |
Hypothyroidism | 12 (4.2) | 13 (4.5) | 9 (3.1) | 0.672 |
Laboratory tests: | Â | Â | Â | Â |
GGT(SD), IU/L | 48.8 (68.7) | 52.3 (80.9) | 77.2 (91.1) | < 0.001 |
Cholesterol (SD), mmol/L | 3.76 (0.90) | 3.99 (0.92) | 4.29 (1.07) | < 0.001 |
LDL(SD), mmol/L | 2.09 (0.74) | 2.29 (0.78) | 2.51 (0.92) | < 0.001 |
HDL(SD), mmol/L | 1.31 (0.38) | 1.18 (0.31) | 1.04 (0.34) | < 0.001 |
SUA(SD), umol/L | 336 (113) | 365 (123) | 404 (144) | < 0.001 |
SCR(SD), umol/L | 93.4 (63.3) | 98.3 (93.4) | 132 (143) | < 0.001 |
NT-pro BNP(SD), ng/L | 2313 (4073) | 2588 (5052) | 5841 (9057) | < 0.001 |
Unknown (%) | 40(13.9) | 29(10.1) | 25(8.7%) | Â |
Echocardiogram data: | Â | Â | Â | Â |
LAD(SD), mm | 41.7 (8.72) | 40.8 (7.84) | 41.0 (7.64) | 0.446 |
Unknown (%) | 11(3.8) | 19(6.6) | 32(11.11) | Â |
LVD(SD), mm | 48.3 (6.05) | 47.7 (6.29) | 49.5 (8.48) | 0.010 |
Unknown (%) | 12(4.2) | 19(6.6) | 32(11.11) | Â |
RAD(SD), mm | 41.9 (8.71) | 39.6 (8.18) | 40.3 (7.78) | 0.005 |
Unknown (%) | 16(5.6) | 28(9.7) | 51(17.7) | Â |
RVD(SD), mm | 22.4 (3.07) | 22.0 (3.08) | 22.0 (3.46) | 0.302 |
Unknown (%) | 12(4.2) | 22(7.6) | 45(15.6) | Â |
LVEF(SD), % | 61.2 (10.4) | 61.4 (11.3) | 57.9 (14.1) | 0.001 |
Unknown (%) | 11(3.8) | 20(6.9) | 33(11.5) | Â |
Medications, % | Â | Â | Â | Â |
OAC only | 188 (65.3) | 187 (64.9) | 148 (51.4) | 0.001 |
Antiplatelet only | 23 (8.0) | 24 (8.3) | 28 (9.7) | 0.736 |
OAC + Antiplatelet | 20 (6.9) | 21 (7.3) | 24 (8.3) | 0.806 |
ARNI/ACEI/ARB: | 64 (22.2) | 62 (21.5) | 62 (21.5) | 0.973 |
β-blocker: | 80 (27.8) | 93 (32.3) | 95 (33.0) | 0.341 |
Statin: | 69 (24.0) | 87 (30.2) | 88 (30.6) | 0.141 |